Acute & Long-Term Cardiac Effects of COVID-19

Stanford Medicine

E. Profita

What Are the Considerations for Management of ST-Elevation Myocardia…

Northwestern Medicine Cardiovascular Care

R. Bach

COVID-19 and Heart Failure

24th Annual Heart Failure 2020: an Update on Therapy

M. Mehra

COVID-19 and Heart Failure: How to Evaluate Patients? Can You Give B…

Houston Methodist DeBakey Heart and Vascular Center

N. Fida

COVID-19: What Types of Thrombosis Are Commonly Seen? Are Anticoagul…

Mount Sinai

J. Olin

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Keck School of Medicine of USC

L. Clavijo

What We Learned from COVID-19

UCLA Health

O. Emeruwa

COVID-19: Should ACE inhibitors and Angiotensin Receptor Blockers Be…

Cardiometabolic Health Congress (CMHC)

K. Ferdinand

ST-segment Elevation in Patients with COVID-19: What Is the Mechanis…

Sripal Bangalore

Heart Team Summit: COVID-19 Town Hall, recorded 4.16.20

Northwestern Medicine Cardiovascular Care

R. Damiano, P. McCarthy, A. Zajarias, J. Flaherty, D. Heimansohn, C. Davidson, N. Quader, J. Hermiller

Clinical Insights on COVID 19 from the American College of Cardiolog…

Tom Maddox

J. Rumsfeld

Clinical Status of COVID-19 Patients Combined with CVD: What Drug Op…

American College of Cardiology

Y. Chen

Long-Covid: Expectations and Management

Michigan Medicine

S. Hayek

Should Troponin Be Checked in All Patients Who Are Admitted to the H…

Cardiometabolic Health Congress (CMHC)

C. Ballantyne

ICU Management for COVID 19 Patients: What Are the Anticoagulation S…

37th Annual Advances in Heart Disease

A. Gomez, P. Hsue

COVID-19: What We Have Learned about Treating Patients with ECMO, To…

Northwestern Medicine Cardiovascular Care

F. Masood

Myocarditis Associated with COVID-19 Infection and Vaccines

Canadian Collaborative Research Network

M. Chetrit

Tall Rounds®: Thrombotic Complications and Hypercoagulability associ…

Cleveland Clinic Heart, Vascular and Thoracic Institute

J. Bishop